Abstract
Naphthyridinomycin is a novel quinone antibiotic that is produced in liquid shake cultures by Streptomyces lusitanus. Fermentation studies have shown that this antibiotic is produced maximally after 96 h of cell growth. L-[methyl-3H]methionine efficiently labels naphthyridinomycin when it is added to a fermentation mixture 24 h before culture is harvested. Unlabeled and radioactively labeled naphthyridinomycin were used to determine the mechanism of action of this unique antibiotic. Naphthyridinomycin inhibited bacterial growth primarily by inhibiting DNA synthesis. The structural similarity between naphthyridinomycin and the saframycins suggested that naphthyridinomycin might inhibit DNA synthesis by binding to the template. In vitro studies with radiolabeled naphthyridinomycin indicated that this antibiotic does specifically bind to calf thymus DNA. The binding reaction was enhanced by adding sulfhydryl-containing compounds; dithiothreitol was the best activating agent. DNA-naphthyridinomycin complexes were a poor substrate for enzymes that catalyze DNA-directed DNA and RNA syntheses. These results showed that naphthyridinomycin is similar to the saframycins in its reactivity toward DNA and suggested that the mechanism by which naphthyridinomycin inhibits DNA synthesis is through its ability to bind specifically to the DNA template of the cell.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arai T., Takahashi K., Ishiguro K., Yazawa K. Increased production of saframycin A and isolation of saframycin S. J Antibiot (Tokyo) 1980 Sep;33(9):951–960. doi: 10.7164/antibiotics.33.951. [DOI] [PubMed] [Google Scholar]
- Arai T., Takahashi K., Nakahara S., Kubo A. The structure of a novel antitumor antibiotic, saframycin A. Experientia. 1980 Sep 15;36(9):1025–1027. doi: 10.1007/BF01965946. [DOI] [PubMed] [Google Scholar]
- Burgess R. R. A new method for the large scale purification of Escherichia coli deoxyribonucleic acid-dependent ribonucleic acid polymerase. J Biol Chem. 1969 Nov 25;244(22):6160–6167. [PubMed] [Google Scholar]
- Hurley L. H., Gairola C., Zmijewski M. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules. Biochim Biophys Acta. 1977 Apr 4;475(3):521–535. doi: 10.1016/0005-2787(77)90067-3. [DOI] [PubMed] [Google Scholar]
- Hurley L. H., Petrusek R. Proposed structure of the anthramycin-DNA adduct. Nature. 1979 Nov 29;282(5738):529–531. doi: 10.1038/282529a0. [DOI] [PubMed] [Google Scholar]
- Ishiguro K., Sakiyama S., Takahashi K., Arai T. Mode of action of saframycin A, a novel heterocyclic quinone antibiotic. Inhibition of RNA synthesis in vivo and in vitro. Biochemistry. 1978 Jun 27;17(13):2545–2550. doi: 10.1021/bi00606a014. [DOI] [PubMed] [Google Scholar]
- Ishiguro K., Takahashi K., Yazawa K., Sakiyama S., Arai T. Binding of saframycin A, a heterocyclic quinone anti-tumor antibiotic to DNA as revealed by the use of the antibiotic labeled with [14C]tyrosine or [14C]cyanide. J Biol Chem. 1981 Mar 10;256(5):2162–2167. [PubMed] [Google Scholar]
- Kluepfel D., Baker H. A., Piattoni G., Sehgal S. N., Sidorowicz A., Singh K., Vézina C. Naphthyridinomycin, a new broad-spectrum antibiotic. J Antibiot (Tokyo) 1975 Jul;28(7):497–502. doi: 10.7164/antibiotics.28.497. [DOI] [PubMed] [Google Scholar]
- Tomasz M., Mercado C. M., Olson J., Chatterjie N. The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro. Biochemistry. 1974 Nov 19;13(24):4878–4887. doi: 10.1021/bi00721a002. [DOI] [PubMed] [Google Scholar]